418 related articles for article (PubMed ID: 19887783)
1. Prognostic factors of treatment outcomes in patients with granulocytic sarcoma.
Lan TY; Lin DT; Tien HF; Yang RS; Chen CY; Wu K
Acta Haematol; 2009; 122(4):238-46. PubMed ID: 19887783
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma.
Shimizu H; Saitoh T; Tanaka M; Mori T; Sakura T; Kawai N; Kanda Y; Nakaseko C; Yano S; Fujita H; Fujisawa S; Miyawaki S; Kanamori H; Okamoto S
Leukemia; 2012 Dec; 26(12):2469-73. PubMed ID: 22699453
[TBL] [Abstract][Full Text] [Related]
3. Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy.
Tsimberidou AM; Kantarjian HM; Estey E; Cortes JE; Verstovsek S; Faderl S; Thomas DA; Garcia-Manero G; Ferrajoli A; Manning JT; Keating MJ; Albitar M; O'Brien S; Giles FJ
Leukemia; 2003 Jun; 17(6):1100-3. PubMed ID: 12764375
[TBL] [Abstract][Full Text] [Related]
4. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
Abdelhameed A; Pond GR; Mitsakakis N; Brandwein J; Chun K; Gupta V; Kamel-Reid S; Lipton JH; Minden MD; Schimmer A; Schuh A; Yee K; Messner HA
Cancer; 2008 Apr; 112(7):1513-21. PubMed ID: 18286528
[TBL] [Abstract][Full Text] [Related]
5. Good outcome of children with acute myeloid leukemia and t(8;21)(q22;q22), even when associated with granulocytic sarcoma: a report from a single institution in Argentina.
Felice MS; Zubizarreta PA; Alfaro EM; Gallego MS; Cygler AM; Rosso DA; Rossi JG; Sackmann-Muriel F
Cancer; 2000 Apr; 88(8):1939-44. PubMed ID: 10760772
[TBL] [Abstract][Full Text] [Related]
6. Age 40 years and under does not confer superior prognosis in patients with multiple myeloma undergoing upfront autologous stem cell transmplant.
Cheema PK; Zadeh S; Kukreti V; Reece D; Chen C; Trudel S; Mikhael J
Biol Blood Marrow Transplant; 2009 Jun; 15(6):686-93. PubMed ID: 19450753
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC.
Chevallier P; Mohty M; Lioure B; Michel G; Contentin N; Deconinck E; Bordigoni P; Vernant JP; Hunault M; Vigouroux S; Blaise D; Tabrizi R; Buzyn A; Socie G; Michallet M; Volteau C; Harousseau JL
J Clin Oncol; 2008 Oct; 26(30):4940-3. PubMed ID: 18606981
[TBL] [Abstract][Full Text] [Related]
8. Myeloid (granulocytic) sarcoma of epididymis as rare manifestation of recurrent acute myelogenous leukemia.
Sarvis JA; Auge BK
Urology; 2009 May; 73(5):1163.e1-3. PubMed ID: 18602141
[TBL] [Abstract][Full Text] [Related]
9. Physicians' prognostic estimates of survival for patients undergoing allogeneic hematopoietic stem cell transplantation.
Grulke N; Bunjes D; Larbig W; Kächele H; Bailer H
J Psychosom Res; 2008 Jul; 65(1):61-6. PubMed ID: 18582613
[TBL] [Abstract][Full Text] [Related]
10. Granulocytic sarcoma: report of three cases.
Mwanda WO; Rajab JA
East Afr Med J; 1999 Oct; 76(10):594-6. PubMed ID: 10734514
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of acute myeloid leukemia presenting as myeloid sarcoma.
Avni B; Rund D; Levin M; Grisariu S; Ben-Yehuda D; Bar-Cohen S; Paltiel O
Hematol Oncol; 2012 Mar; 30(1):34-40. PubMed ID: 21638303
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of clinical outcomes and prognostic factors for synovial sarcoma arising from the extremities.
Sakabe T; Murata H; Konishi E; Takeshita H; Ueda H; Matsui T; Horie N; Yanagisawa A; Kubo T
Med Sci Monit; 2008 Jun; 14(6):CR305-310. PubMed ID: 18509273
[TBL] [Abstract][Full Text] [Related]
13. Is there a "gold" standard treatment for patients with isolated myeloid sarcoma?
Antic D; Elezovic I; Milic N; Suvajdzic N; Vidovic A; Perunicic M; Djunic I; Mitrovic M; Tomin D
Biomed Pharmacother; 2013 Feb; 67(1):72-7. PubMed ID: 23218987
[TBL] [Abstract][Full Text] [Related]
14. Clinical and prognostic features of Nigerians with chronic myeloid leukemia.
Boma PO; Durosinmi MA; Adediran IA; Akinola NO; Salawu L
Niger Postgrad Med J; 2006 Mar; 13(1):47-52. PubMed ID: 16633379
[TBL] [Abstract][Full Text] [Related]
15. Optimal treatment strategy for intracranial germ cell tumors: a single institution analysis.
Kanamori M; Kumabe T; Saito R; Yamashita Y; Sonoda Y; Ariga H; Takai Y; Tominaga T
J Neurosurg Pediatr; 2009 Dec; 4(6):506-14. PubMed ID: 19951035
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.
Thirugnanam R; George B; Chendamarai E; Lakshmi KM; Balasubramanian P; Viswabandya A; Srivastava A; Chandy M; Mathews V
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1479-84. PubMed ID: 19822309
[TBL] [Abstract][Full Text] [Related]
17. Renal dysfunction after total-body irradiation. Significance of selective renal shielding blocks.
Igaki H; Karasawa K; Sakamaki H; Saito H; Nakagawa K; Ohtomo K; Tanaka Y
Strahlenther Onkol; 2005 Nov; 181(11):704-8. PubMed ID: 16254705
[TBL] [Abstract][Full Text] [Related]
18. Granulocytic sarcoma of pediatric head and neck: an institutional experience.
Roby BB; Drehner D; Sidman JD
Int J Pediatr Otorhinolaryngol; 2013 Aug; 77(8):1364-6. PubMed ID: 23810551
[TBL] [Abstract][Full Text] [Related]
19. [The prognostic factors in chronic myeloleukemia].
Khoroshko ND
Ter Arkh; 1993; 65(7):23-8. PubMed ID: 8211773
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiological analysis of leukemia survival in Cracow for cases registered in 1980-1990].
Fornal M; Janicki K; Grodzicki T
Przegl Epidemiol; 2003; 57(4):671-82. PubMed ID: 15029843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
